Stockreport

Sierra Oncology Reports Favorable Long-Term Safety and Dose Intensity Data for Momelotinib

Sierra Oncology, Inc.  (SRRA) 
Last sierra oncology, inc. earnings: 3/3 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sierraoncology.com
PDF - Data presented at the 25th European Hematology Association (EHA) Virtual Congress further demonstrate the potential anemia benefits and favorable hematological safety [Read more]